Quantcast
Last updated on April 19, 2014 at 18:42 EDT

Latest Blood disorders Stories

2012-04-26 06:26:15

WHITE PLAINS, N.Y., April 26, 2012 /PRNewswire/ -- Thanks to funding from The Leukemia & Lymphoma Society (LLS), Epizyme has been advancing DOT1L, a targeted histone methyltransferase inhibitor (HMTi) as a personalized therapeutic for patients with mixed lineage leukemia (MLL). LLS has committed to providing up to $7.5 million in milestone-based funding to Epizyme to support the program through a Phase 1 clinical trial. Epizyme's partnership with Celgene,...

2012-04-26 09:23:08

Reducing oxidative stress through exercise may eventually be used to treat sickle cell disease Sickle cell disease (SCD), an inherited condition that causes red blood cells to sometimes deform into a crescent shape, affects an estimated 100,000 Americans, typically those of African descent. However, far more have sickle cell trait (SCT), caused when individuals carry just a single copy of the disease-causing mutation in their genes. Rather than all their red blood cells being affected,...

2012-04-24 22:29:26

Although people generally talk about "cancer", it is clear that the disease occurs in a bewildering variety of forms. Even single groups of cancers, such as those of the white blood cells, may show widely differing properties. How do the various cancers arise and what factors determine their progression? Clues to these two issues, at least for leukemias, have now been provided by Boris Kovacic and colleagues at the University of Veterinary Medicine, Vienna (Vetmeduni Vienna). The results are...

2012-04-24 22:25:59

Investment in 7 distinct areas will provide greatest medical benefits The American Society of Hematology (ASH), the world's largest professional society committed to the study and treatment of blood disorders, today issued a report urging federal agencies to coordinate hematology research funding around seven specific high-need areas that would produce the greatest impact and translate into improvements in patient care in the United States. Developed by the Society's Committee on...

2012-04-24 02:30:41

Investment in Seven Distinct Areas Will Provide Greatest Medical Benefits WASHINGTON, April 24, 2012 /PRNewswire-USNewswire/ -- The American Society of Hematology (ASH), the world's largest professional society committed to the study and treatment of blood disorders, today issued a report urging federal agencies to coordinate hematology research funding around seven specific high-need areas that would produce the greatest impact and translate into improvements in patient care in...

2012-04-24 02:28:48

MISSISSAUGA, Ontario, April 24, 2012 /PRNewswire/ -- Kai Goulbourne is only eleven years old, but his life could be cut short if a matching bone marrow donor is not found soon. He was originally diagnosed in December of 2009, when his mom Shelley and Dad noticed, that despite having a healthy appetite, he appeared to be losing weight. Testing and examinations revealed an enlarged spleen, and he was diagnosed as having Chronic Myelogenous Leukemia. It is largely a genetic disorder where the...

2012-04-19 22:20:16

SEATTLE, April 20, 2012 /PRNewswire/ -- Cell Therapeutics, Inc. ("CTI" or the "Company") (NASDAQ and MTA: CTIC) today reported financial results and recent accomplishments for the first quarter of 2012. First Quarter Financial Results For the quarter ended March 31, 2012, total operating expenses were $18.1 million compared to $20.1 million for the same period in 2011. Net loss attributable to common shareholders decreased 66% to $17.4 million ($0.09 per share) for the quarter ended March...

2012-04-19 23:03:04

Just over two years ago a seemingly healthy Eve Haim, mother of 4, including College Complete CEO Dan Haim, was diagnosed with Myelodysplastic Syndrome (MDS), also known as pre-leukemia, which is caused by the failure of bone marrow to produce proper white cells. That summer, Eve began chemotherapy treatments to no avail, and by year´s end received a transplant. Kansas City, KS (PRWEB) April 19, 2012 Just over two years ago a seemingly healthy Eve Haim, mother of 4 including College...

2012-04-19 06:26:56

WHITE PLAINS, N.Y., April 19, 2012 /PRNewswire-USNewswire/ -- The Leukemia & Lymphoma Society (LLS) salutes Carl June, M.D., of University of Pennsylvania School of Medicine, and the members of his team, for the latest recognition of their groundbreaking advances in immunotherapy. Today the Clinical Research Forum announced Dr. June's lab as among its Top 10 Clinical Research Achievement Awards. The awards recognize studies, all published within the last two years, that represent...

2012-04-19 02:28:04

WASHINGTON, April 19, 2012 /PRNewswire-USNewswire/ -- The American Society of Hematology (ASH), the world's largest organization concerned with the causes and treatment of blood disorders, today released the Blood journal app for iPhone and iPad. Blood is the official Journal of the Society and the most cited peer-reviewed publication in the field. By downloading the free application, users can access First Edition articles, conduct full-text searches, and view listings of articles by author...